GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Interest Coverage

J.Molner AS (OTSE:MOLNR) Interest Coverage : 0 (At Loss) (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. J.Molner AS's Operating Income for the six months ended in Dec. 2023 was €-0.56 Mil. J.Molner AS's Interest Expense for the six months ended in Dec. 2023 was €-0.10 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for J.Molner AS's Interest Coverage or its related term are showing as below:


OTSE:MOLNR's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.505
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


J.Molner AS Interest Coverage Historical Data

The historical data trend for J.Molner AS's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

J.Molner AS Interest Coverage Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Interest Coverage
- - -

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Interest Coverage N/A - - - -

Competitive Comparison of J.Molner AS's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


J.Molner AS's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Interest Coverage distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Interest Coverage falls into.



J.Molner AS Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

J.Molner AS's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, J.Molner AS's Interest Expense was €-0.16 Mil. Its Operating Income was €-0.95 Mil. And its Long-Term Debt & Capital Lease Obligation was €1.91 Mil.

J.Molner AS did not have earnings to cover the interest expense.

J.Molner AS's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, J.Molner AS's Interest Expense was €-0.10 Mil. Its Operating Income was €-0.56 Mil. And its Long-Term Debt & Capital Lease Obligation was €1.91 Mil.

J.Molner AS did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


J.Molner AS  (OTSE:MOLNR) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


J.Molner AS Interest Coverage Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines